Clinical Trial Update: Navigator vs Standard Needle Injection for Hip [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing the Navigator device to standard needle injection for hip pain with unknown etiology has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Pain

Snippet

Sponsor: Cartiva, Inc. | Conditions: Hip Pain Etiology Unknown | Phase 2 | Status: COMPLETED